Penfluridol maintenance therapy in schizophrenia: a controlled study.

Area of Science:

• Psychiatry
• Pharmacology
• Clinical Neuroscience

Background:

• Schizophrenia requires long-term management.
• Maintenance therapy aims to prevent relapse and improve outcomes.

Purpose of the Study:

• To evaluate the efficacy of penfluridol as a maintenance therapy for chronic schizophrenic patients.
• To compare the need for adjunctive haloperidol in patients receiving penfluridol versus placebo.

Main Methods:

• A 12-week, double-blind, placebo-controlled study.
• Twenty-eight chronic schizophrenic patients were randomized to penfluridol or placebo.
• Haloperidol was administered as needed for symptom exacerbation.

Main Results:

• Only 1 of 14 patients on penfluridol required adjunctive haloperidol.
• 12 of 14 patients on placebo required adjunctive haloperidol.
• No significant differences in overall clinical ratings between groups or over time.

Conclusions:

• Penfluridol demonstrates efficacy in reducing the need for additional antipsychotic medication during maintenance therapy.
• The findings support previous reports on penfluridol's suitability for long-term schizophrenia management.
• Penfluridol may offer a more stable treatment course compared to placebo with rescue medication.